Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Clinical trial NCT02942706 · UNKNOWN

Trial details

NCT number: NCT02942706
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2021-11-01
Primary completion: 2022-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.